Akebia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. 

CEO
John P. Butler, MBA
CEOJohn P. Butler, MBA
Employees
194
Employees194
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
194
Employees194

AKBA Key Statistics

Market cap
237.86M
Market cap237.86M
Price-Earnings ratio
-7.86
Price-Earnings ratio-7.86
Dividend yield
Dividend yield
Average volume
6.10M
Average volume6.10M
High today
$0.8898
High today$0.8898
Low today
$0.8581
Low today$0.8581
Open price
$0.87
Open price$0.87
Volume
2.09M
Volume2.09M
52 Week high
$3.32
52 Week high$3.32
52 Week low
$0.8227
52 Week low$0.8227

Stock Snapshot

Akebia Therapeutics(AKBA) stock is priced at $0.87, giving the company a market capitalization of 237.86M. It carries a P/E multiple of -7.86.

On 2026-08-15, Akebia Therapeutics(AKBA) stock traded between a low of $0.86 and a high of $0.89. Shares are currently priced at $0.87, which is +1.6% above the low and -2.0% below the high.

The Akebia Therapeutics(AKBA)'s current trading volume is 2.09M, compared to an average daily volume of 6.1M.

In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $3.32 and a 52-week low of $0.82.

In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $3.32 and a 52-week low of $0.82.

People also own

Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.